Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6314)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2014 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tao LL, Shi SJ, Chen LB, Huang GC. Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia. World J Gastroenterol 2014; 20(15): 4421-4427 [PMID: 24764682 DOI: 10.3748/wjg.v20.i15.4421] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4421.htm |
| Number | Citing Articles |
| 1 |
Anne Riemann, Sarah Reime, Oliver Thews. Tumor Acidosis and Hypoxia Differently Modulate the Inflammatory Program: Measurements In Vitro and In Vivo. Neoplasia 2017; 19(12): 1033 doi: 10.1016/j.neo.2017.09.005
|
| 2 |
Yan-Ting Li, Wen-Zhen Yuan, Wei-Lin Jin. Vagus innervation in the gastrointestinal tumor: Current understanding and challenges. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(3): 188884 doi: 10.1016/j.bbcan.2023.188884
|
| 3 |
Faruk Tas, Senem Karabulut, Murat Serilmez, Mehmet Karabulut, Derya Duranyildiz. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer. Cancer Chemotherapy and Pharmacology 2016; 77(1): 127 doi: 10.1007/s00280-015-2886-5
|
| 4 |
Na Li, Yang Li, Zengxun Li, Chongbiao Huang, Yanhui Yang, Mingxiao Lang, Junli Cao, Wenna Jiang, Yu Xu, Jie Dong, He Ren. Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2016; 17(6): 799 doi: 10.3390/ijms17060799
|
| 5 |
Elzbieta Pawluczuk, Marta Łukaszewicz-Zając, Barbara Mroczko. The Role of Chemokines in the Development of Gastric Cancer—Diagnostic and Therapeutic Implications. International Journal of Molecular Sciences 2020; 21(22): 8456 doi: 10.3390/ijms21228456
|
| 6 |
Guichun Huang, Leilei Tao, Sunan Shen, Longbang Chen. Hypoxia induced CCL28 promotes angiogenesis in lung adenocarcinoma by targeting CCR3 on endothelial cells. Scientific Reports 2016; 6(1) doi: 10.1038/srep27152
|
| 7 |
Genevieve Hartley, Daniel Regan, Amanda Guth, Steven Dow. Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α. Cancer Immunology, Immunotherapy 2017; 66(4): 523 doi: 10.1007/s00262-017-1955-5
|
| 8 |
Abhilasha Sharma, Sonam Sinha, Neeta Shrivastava. Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.849040
|
| 9 |
Seungyeon Ryu, Myeongwoo Jung, Chongtae Kim, Hoin Kang, Sukyoung Han, Seongho Cha, Seung Min Jeong, Eun Kyung Lee. Loss of RNA binding protein HuD facilitates the production of the senescence-associated secretory phenotype. Cell Death & Disease 2022; 13(4) doi: 10.1038/s41419-022-04792-y
|
| 10 |
Cemre Ucaryilmaz Metin, Gulnihal Ozcan. The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer. Cancers 2022; 14(11): 2711 doi: 10.3390/cancers14112711
|
| 11 |
Wai Hoong Chang, Alvina G. Lai. The hypoxic tumour microenvironment: A safe haven for immunosuppressive cells and a therapeutic barrier to overcome. Cancer Letters 2020; 487: 34 doi: 10.1016/j.canlet.2020.05.011
|
| 12 |
Su Yin Lim, Arseniy E. Yuzhalin, Alex N. Gordon-Weeks, Ruth J. Muschel. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget 2016; 7(19): 28697 doi: 10.18632/oncotarget.7376
|
| 13 |
Hiroaki Iwamoto, Kouji Izumi, Atsushi Mizokami. Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?. International Journal of Molecular Sciences 2020; 21(23): 9328 doi: 10.3390/ijms21239328
|
| 14 |
L. V. Matveeva, R. C. Kapkaeva, A. N. Chudajkin, L. S. Mishanina. CHANGES MONOCYTE CHEMOATTRACTANTS PROTEIN-1 IN HELICOBACTER PYLORIASSOCIATED GASTRODUODENAL DISEASES. Russian Journal of Infection and Immunity 2018; 8(2): 150 doi: 10.15789/2220-7619-2018-2-150-156
|
| 15 |
Takumi Kishimoto, Nobukazu Fujimoto, Takeshi Ebara, Toyonori Omori, Tetsuya Oguri, Akio Niimi, Takako Yokoyama, Munehiro Kato, Ikuji Usami, Masayuki Nishio, Kosho Yoshikawa, Takeshi Tokuyama, Mouka Tamura, Yoshifumi Yokoyama, Ken Tsuboi, Yoichi Matsuo, Jiegou Xu, Satoru Takahashi, Mohamed Abdelgied, William T. Alexander, David B. Alexander, Hiroyuki Tsuda. Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6419-1
|
| 16 |
Ping Wang, Fei Guo, Lin Han, Xi'ai Wang, Jie Li, Yan Guo, Yumin LÜ. X-ray-Induced Changes in the Expression of Inflammation-Related Genes in Human Peripheral Blood. International Journal of Molecular Sciences 2014; 15(11): 19516 doi: 10.3390/ijms151119516
|
| 17 |
Y. Sunakawa, S. Stremitzer, S. Cao, W. Zhang, D. Yang, T. Wakatsuki, Y. Ning, S. Yamauchi, S. Stintzing, A. Sebio, R. El-khoueiry, S. Matsusaka, A. Parekh, A. Barzi, M. Azuma, M. Watanabe, W. Koizumi, H.-J. Lenz. Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer. Annals of Oncology 2015; 26(2): 332 doi: 10.1093/annonc/mdu542
|
| 18 |
Liam Friel Tremble, Patrick F. Forde, Declan M. Soden. Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges. Cancer Immunology, Immunotherapy 2017; 66(12): 1509 doi: 10.1007/s00262-017-2065-0
|
| 19 |
Guohua Yu, Wubin Wang, Xu Wang, Meng Xu, Lili Zhang, Lei Ding, Rui Guo, Yuanyuan Shi. Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis. BMC Complementary and Alternative Medicine 2018; 18(1) doi: 10.1186/s12906-018-2356-9
|
| 20 |
Razvan Onciul, Felix-Mircea Brehar, Corneliu Toader, Razvan-Adrian Covache-Busuioc, Luca-Andrei Glavan, Bogdan-Gabriel Bratu, Horia Petre Costin, David-Ioan Dumitrascu, Matei Serban, Alexandru Vlad Ciurea. Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas. Current Issues in Molecular Biology 2024; 46(3): 2402 doi: 10.3390/cimb46030153
|
| 21 |
Josh W. DiGiacomo, Daniele M. Gilkes. Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies. Targeted Oncology 2018; 13(2): 157 doi: 10.1007/s11523-018-0555-4
|
| 22 |
JIE CAI, MEI WANG, MENGCHU ZHU, QIANG ZHANG, XU ZHANG, YONGMIN YAN, HUI QIAN, WENRONG XU. N-methyl-N-nitro-N′-nitrosoguanidine induces the expression of CCR2 in human gastric epithelial cells promoting CCL2-mediated migration. Molecular Medicine Reports 2016; 13(2): 1083 doi: 10.3892/mmr.2015.4650
|
| 23 |
Yan-Li Li, Zhi-Hu Shi, Xian Wang, Kang-Sheng Gu, Zhi-min Zhai. Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma. Annals of Hematology 2019; 98(2): 413 doi: 10.1007/s00277-018-3522-3
|
| 24 |
Xiaoting Ma, Kai Ou, Xiu Liu, Lin Yang. Application progress of liquid biopsy in gastric cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.969866
|
| 25 |
Maosen Xu, Yang Wang, Ruolan Xia, Yuquan Wei, Xiawei Wei. Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. Cell Proliferation 2021; 54(10) doi: 10.1111/cpr.13115
|
| 26 |
Elisa Paolicchi, Federica Gemignani, Marija Krstic-Demonacos, Shoukat Dedhar, Luciano Mutti, Stefano Landi. Targeting hypoxic response for cancer therapy. Oncotarget 2016; 7(12): 13464 doi: 10.18632/oncotarget.7229
|
| 27 |
M. Blanca Piazuelo, Rachel P. Riechelmann, Keith T. Wilson, Holly M. Scott Algood. Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter pylori. Current Topics in Microbiology and Immunology 2019; 421: 319 doi: 10.1007/978-3-030-15138-6_13
|
| 28 |
Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, Donata Simińska, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska-Bosiacka. Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review. International Journal of Molecular Sciences 2020; 21(16): 5647 doi: 10.3390/ijms21165647
|
| 29 |
Bei Zhong, Yu Li, Xiaodong Liu, Dongsheng Wang. Association of mast cell infiltration with gastric cancer progression. Oncology Letters 2017; doi: 10.3892/ol.2017.7380
|
| 30 |
Kanae Yumimoto, Shigeaki Sugiyama, Koshi Mimori, Keiichi I. Nakayama. Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents. Cancer Science 2019; 110(7): 2090 doi: 10.1111/cas.14075
|
| 31 |
Ke Chen, Luojian Zhang, Zhen Qu, Feng Wan, Jia Li, Ye Yang, Hui Yan, Shile Huang, Rita Casadio. Uncovering the Mechanisms and Molecular Targets of Weibing Formula 1 against Gastritis: Coupling Network Pharmacology with GEO Database. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5533946
|
| 32 |
Hirokazu Nakatsumi, Masaki Matsumoto, Keiichi I. Nakayama. Noncanonical Pathway for Regulation of CCL2 Expression by an mTORC1-FOXK1 Axis Promotes Recruitment of Tumor-Associated Macrophages. Cell Reports 2017; 21(9): 2471 doi: 10.1016/j.celrep.2017.11.014
|